Skip to main content
Sign In
 

Welcome to Genetics and Metabolism

The Department of Pediatrics Section of Genetics and Metabolism provides clinical services at Children's Hospital Colorado in Aurora, Colorado.  The Department also offers educational programs and pursues clinical and basic research on numerous conditions. 

Please explore our website for more information, and contact us if you have any questions.

 

Clinical ServicesCLINICAL SERVICES
We provide consultative inpatient services at Children's Hospital Colorado and affiliated hospitals and regional outreach programs in Colorado, Wyoming, and Montana.  MORE »



EducationEDUCATION
We offer a variety of educational programs including a two-year Fellowship/Residency Program in Genetics at Children's Hospital Colorado.  MORE »



ResearchRESEARCH
We pursue clinical and basic research on numerous inherited conditions. Translational research efforts are bringing our new findings to clinical care through our service laboratories. MORE »

HIGHLIGHTS & NEWS

  • "Janet Thomas, MD, will assume the role of Interim Section Head for the Section of Genetics on January 1, 2017. I know that we will all work hard to support Janet as a search for a permanent Section Head progresses. I also want to take this opportunity to thank Gary Bellus for his service as Interim Section Head. Gary has helped to keep the Section moving forward." - Stephen Daniels, MD, PhD

  • David Manchester, MD, has announced his retirement from the Department of Pediatrics and School of Medicine effective January 1st, 2017. Dr. Manchester joined the Department in 1977 as Assistant Professor, promoted to Associate Professor in 1984, and to Professor in 2000.

  • The Colorado Intellectual and Developmental Disabilities Research Center (IDDRC) aids investigators in our Section in research into intellectual disabilities and related conditions.

  • Clinical research in our Section includes studies to describe the clinical spectrum of disorders, such as skeletal dysplasias, and studies on comprehensive care, including new treatments for neurofibromatosis, lysosomal storage disorders, and phenylketonuria.
​​​​